Generic drugs and brand name products: An approach about excipients

Detalhes bibliográficos
Autor(a) principal: Nogueira, Andreia
Data de Publicação: 2014
Outros Autores: Carvalho, Leticia, Tavares, Raquel, Ribeiro, Maximiano, Coutinho, Paula, Roque, Fátima
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10314/2452
Resumo: In general excipients are considered to be “inert”, however in certain patients under certain circumstances some of them have demonstrated some activity, with increasing reports of adverse reactions. Generic drugs are required to have the same active substances, strength, dosage form and rout of administration as the brand name product, but excipients could be different. The excipients that have recognized action or effects should be declared on the labelling of medicines, and are listed in the Guideline products for human use.
id RCAP_c4d8c60c5c762e8e1282e7d79dce8d5e
oai_identifier_str oai:bdigital.ipg.pt:10314/2452
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Generic drugs and brand name products: An approach about excipientsGeneric drugsBrand name drugsExcipientsAdverse reactionsGuidelinesIn general excipients are considered to be “inert”, however in certain patients under certain circumstances some of them have demonstrated some activity, with increasing reports of adverse reactions. Generic drugs are required to have the same active substances, strength, dosage form and rout of administration as the brand name product, but excipients could be different. The excipients that have recognized action or effects should be declared on the labelling of medicines, and are listed in the Guideline products for human use.2014-01-01T00:00:00Z2016-07-07info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10314/2452http://hdl.handle.net/10314/2452eng0034-89130Nogueira, AndreiaCarvalho, LeticiaTavares, RaquelRibeiro, MaximianoCoutinho, PaulaRoque, Fátimainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-01-14T02:55:24Zoai:bdigital.ipg.pt:10314/2452Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T01:42:03.134599Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Generic drugs and brand name products: An approach about excipients
title Generic drugs and brand name products: An approach about excipients
spellingShingle Generic drugs and brand name products: An approach about excipients
Nogueira, Andreia
Generic drugs
Brand name drugs
Excipients
Adverse reactions
Guidelines
title_short Generic drugs and brand name products: An approach about excipients
title_full Generic drugs and brand name products: An approach about excipients
title_fullStr Generic drugs and brand name products: An approach about excipients
title_full_unstemmed Generic drugs and brand name products: An approach about excipients
title_sort Generic drugs and brand name products: An approach about excipients
author Nogueira, Andreia
author_facet Nogueira, Andreia
Carvalho, Leticia
Tavares, Raquel
Ribeiro, Maximiano
Coutinho, Paula
Roque, Fátima
author_role author
author2 Carvalho, Leticia
Tavares, Raquel
Ribeiro, Maximiano
Coutinho, Paula
Roque, Fátima
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Nogueira, Andreia
Carvalho, Leticia
Tavares, Raquel
Ribeiro, Maximiano
Coutinho, Paula
Roque, Fátima
dc.subject.por.fl_str_mv Generic drugs
Brand name drugs
Excipients
Adverse reactions
Guidelines
topic Generic drugs
Brand name drugs
Excipients
Adverse reactions
Guidelines
description In general excipients are considered to be “inert”, however in certain patients under certain circumstances some of them have demonstrated some activity, with increasing reports of adverse reactions. Generic drugs are required to have the same active substances, strength, dosage form and rout of administration as the brand name product, but excipients could be different. The excipients that have recognized action or effects should be declared on the labelling of medicines, and are listed in the Guideline products for human use.
publishDate 2014
dc.date.none.fl_str_mv 2014-01-01T00:00:00Z
2016-07-07
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10314/2452
http://hdl.handle.net/10314/2452
url http://hdl.handle.net/10314/2452
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0034-89130
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1817551334992248832

Registros relacionados